Search
plerixafor (Mozobil)
Indications:
- used prior to stem cell transplantation
- non-Hodgkin lymphoma, multiple myeloma
- investigational for treatment of NSCLC [2,3]
Mechanism of action:
- hematopoietic stem cell mobilizer
- maximizes stem cell collection
- CXCR4 antagonist [2,3]
Notes: Manufacturer: Genzyme
Related
propofol (Diprivan)
General
general anesthetic injectable
antineoplastic agent (chemotherapeutic agent)
Database Correlations
PUBCHEM cid=16727404
References
- Prescriber's Letter 16(2): 2009
New Drugs Approved by the FDA in 2008
Detail-Document#: 250213
(subscription needed) http://www.prescribersletter.com
- Burger JA, Stewart DJ.
CXCR4 chemokine receptor antagonists: perspectives in SCLC.
Expert Opin Investig Drugs. 2009 Apr;18(4):481-90. Review.
PMID: 19335276
- Burger JA, Stewart DJ, Wald O, Peled A.
Potential of CXCR4 antagonists for the treatment of metastatic
lung cancer.
Expert Rev Anticancer Ther. 2011 Apr;11(4):621-30. Review.
PMID: 21504328